TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has shared an announcement.
FIL Limited has increased its stake in Recce Pharmaceuticals Ltd., raising its voting power from 6.40% to 8.57% by acquiring an additional 7,950,744 common shares. This change in substantial holding reflects a growing confidence in Recce Pharmaceuticals’ strategic direction and potential, potentially impacting the company’s market positioning and stakeholder interests positively.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development of new classes of synthetic anti-infectives designed to address the urgent global health threat posed by antibiotic-resistant superbugs and emerging viral pathogens.
Average Trading Volume: 218,836
Technical Sentiment Signal: Sell
Current Market Cap: A$100.9M
Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.